The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.

Podobne knjige/članki

• The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R.
  od: Chevallier-Greco, A, et al.
  Izdano: (1989)
• Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.
  od: Chevallier-Greco, A, et al.
  Izdano: (1986)
• The Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.
  od: Buisson, M, et al.
  Izdano: (1989)
• A particular DNA structure is required for the function of a cis-acting component of the Epstein-Barr virus OriLyt origin of replication.
  od: Portes-Sentis, S, et al.
  Izdano: (1997)
• The Epstein-Barr virus (EBV) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z.
  od: Gruffat, H, et al.
  Izdano: (1990)